Skip to main content
. Author manuscript; available in PMC: 2011 Mar 16.
Published in final edited form as: FEBS Lett. 2008 Sep 19;582(23-24):3396–3400. doi: 10.1016/j.febslet.2008.08.035

Figure 2. Treatment with LXR ligands reduces stroke-induced neurological deficits.

Figure 2

Neurological deficits were evaluated by the De Ryck, Bederson, and foot fault tests in rats receiving vehicle or GW3965 administered 2 or 6 h after ischemic insult. Tests were performed at 24 h (white columns) and 48 h (black columns) after MCAO. Statistical differences were evaluated with a Mann-Whitney test. Data are expressed the mean score of 5 rats; & P < 0.05 vs. vehicle at 48 h; * p<0.05 vs vehicle at 24 h; ** p<0.01 vs. vehicle at 24 h; # p<0.05 vs. vehicle at 48 h.